Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model

The knowledge of fibrosis progression in chronic hepatitis C and the impact of new treatments on progression is limited by the number of available liver biopsies per patient. Moreover, liver biopsies identify a patient's stage of fibrosis at a given point in time, but cannot quantify the time s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of viral hepatitis 2002-03, Vol.9 (2), p.114-122
Hauptverfasser:	Deuffic-Burban, S., Poynard, T., Valleron, A.-J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged chronic hepatitis C Cohort Studies Disease Progression Female fibrosis Hepatitis C virus Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - pathology Hepatitis C, Chronic - physiopathology Humans Interferons - therapeutic use Liver Cirrhosis - drug therapy Liver Cirrhosis - pathology Liver Cirrhosis - physiopathology Male Markov Chains Markov modelling Middle Aged Models, Statistical prediction risk factors treatment Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!